Asian stock markets were on pace for their best month in decades as developments toward a coronavirus vaccine, and reduced uncertainty in US politics lifted sentiment. The buying momentum has been driven in part by investors increasing their exposure to cyclical and other hard-hit sectors. The benchmark S&P/ASX 200 is on track for its best monthly performance since the late 1980s and the Nikkei 225 heads for the biggest monthly gain since 1990.
